Point of care manufacturing continues to expand across the United States and internationally. The clinical value of in-house additive manufacturing is established. The operational foundations that make it sustainable — workflow integration, regulatory compliance, program structure, and long-term viability — are not yet standardized across the field. Those questions have been the substance of two decades of work at Mayo Clinic.
This session offers an honest operational account of what that experience has produced. We will cover the clinical applications that have proven durable across surgical planning, surgical guide creation, medical education, and research; the quality infrastructure required to fabricate safely within a hospital environment; and the organizational model that has sustained the program through significant changes in technology, reimbursement, and institutional context.
We will also address what is coming next. AI-assisted design, digital twin methodology, and extended reality are being integrated into point of care workflows now — and the foundation of operational experience shapes how that integration is being approached.
This talk provides an overview of what sustained commitment to point of care manufacturing produces over time — and what it ultimately means for the patients we serve.
